These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12464272)

  • 1. The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice.
    Meehan TF; DeLuca HF
    Arch Biochem Biophys; 2002 Dec; 408(2):200-4. PubMed ID: 12464272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.
    Mayne CG; Spanier JA; Relland LM; Williams CB; Hayes CE
    Eur J Immunol; 2011 Mar; 41(3):822-32. PubMed ID: 21287548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.
    Wang Y; Marling SJ; Zhu JG; Severson KS; DeLuca HF
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8501-4. PubMed ID: 22592802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ifng gene is essential for Vdr gene expression and vitamin D₃-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model.
    Spanier JA; Nashold FE; Olson JK; Hayes CE
    J Immunol; 2012 Sep; 189(6):3188-97. PubMed ID: 22896638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D.
    Erben RG; Soegiarto DW; Weber K; Zeitz U; Lieberherr M; Gniadecki R; Möller G; Adamski J; Balling R
    Mol Endocrinol; 2002 Jul; 16(7):1524-37. PubMed ID: 12089348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice.
    Meehan TF; DeLuca HF
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5557-60. PubMed ID: 11929984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UV light suppression of EAE (a mouse model of multiple sclerosis) is independent of vitamin D and its receptor.
    Irving AA; Marling SJ; Seeman J; Plum LA; DeLuca HF
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22552-22555. PubMed ID: 31636184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcitonin/calcitonin gene related peptide-alpha gene is not required for 1alpha,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis.
    Becklund BR; James BJ; Gagel RF; DeLuca HF
    Arch Biochem Biophys; 2009 Aug; 488(2):105-8. PubMed ID: 19563774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with RhoA-ROCK signaling mechanism in autoreactive CD4+ T cells enhances the bioavailability of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis.
    Paintlia AS; Paintlia MK; Hollis BW; Singh AK; Singh I
    Am J Pathol; 2012 Sep; 181(3):993-1006. PubMed ID: 22796435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis.
    Nashold FE; Hoag KA; Goverman J; Hayes CE
    J Neuroimmunol; 2001 Sep; 119(1):16-29. PubMed ID: 11525796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML; Ray S; Swamy N; Holick MF; Ray R
    Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-125a-5p Regulates Vitamin D Receptor Expression in a Mouse Model of Experimental Autoimmune Encephalomyelitis.
    Long HC; Wu R; Liu CF; Xiong FL; Xu Z; He D; Zhang YF; Shao B; Zhang PA; Xu GY; Chu L
    Neurosci Bull; 2020 Feb; 36(2):110-120. PubMed ID: 31428926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice.
    Spach KM; Hayes CE
    J Immunol; 2005 Sep; 175(6):4119-26. PubMed ID: 16148162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nongenomic effects of 1α,25-dihydroxyvitamin D
    Hirota Y; Nakagawa K; Mimatsu S; Sawada N; Sakaki T; Kubodera N; Kamao M; Tsugawa N; Suhara Y; Okano T
    Biochem Biophys Res Commun; 2017 Jan; 483(1):359-365. PubMed ID: 28025137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of 1alpha,25-dihydroxyvitamin D(3) in vitamin D receptor-ablated mice in vivo.
    Endres B; Kato S; DeLuca HF
    Biochemistry; 2000 Feb; 39(8):2123-9. PubMed ID: 10684662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.
    Nashold FE; Spach KM; Spanier JA; Hayes CE
    J Immunol; 2009 Sep; 183(6):3672-81. PubMed ID: 19710457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis.
    Spach KM; Nashold FE; Dittel BN; Hayes CE
    J Immunol; 2006 Nov; 177(9):6030-7. PubMed ID: 17056528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D
    Shiri-Shahsavar MR; Mirshafiee A; Parastouei K; Ebrahimi-Kalan A; Yekaninejad S; Soleymani F; Chahardoli R; Mazaheri Nezhad Fard R; Saboor-Yaraghi AA
    J Mol Neurosci; 2016 Dec; 60(4):498-508. PubMed ID: 27647308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and its immunoregulatory role in multiple sclerosis.
    Niino M
    Drugs Today (Barc); 2010 Apr; 46(4):279-90. PubMed ID: 20502725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.